Seeking Alpha

ISIS Pharmaceuticals (ISIS): Q2 EPS of -$0.01 beats by $0.07. Revenue of $47.3M (+91% Y/Y) beats...

ISIS Pharmaceuticals (ISIS): Q2 EPS of -$0.01 beats by $0.07. Revenue of $47.3M (+91% Y/Y) beats by $7.3M. (PR)
From other sites
Comments (1)
  • Ben Around
    , contributor
    Comments (125) | Send Message
     
    In a normal [?] market ISIS Should open and stay high on this news.
    Will it get back near 13? It should be there.
    If it stays at 12, I will be a buyer.
    6 Aug 2012, 09:04 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs